Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001780088-26-000006

CHIEF MEDICAL OFFICER sold 14,311 shares at an average $31.92 ($456,835)

  • CHIEF MEDICAL OFFICER acquired 1,365 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ticho Barry · CHIEF MEDICAL OFFICER

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-17 Sale : show line 1 in the form 10b5-1 −3,577 $32.74 $117,109 50,071 D
2026-03-17 Sale : show line 2 in the form 10b5-1 −2,587 $33.38 $86,342 47,484 D
2026-03-18 Sale : show line 3 in the form 10b5-1 −6,100 $31.28 $190,831 41,384 D
2026-03-18 Sale : show line 4 in the form 10b5-1 −483 $31.79 $15,354 40,901 D
2026-03-18 Sale : show line 5 in the form 10b5-1 −103 $32.85 $3,384 40,798 D
2026-03-19 Exercise or conversion : show line 6 in the form 10b5-1 +1,365 $2.19 $2,989 42,163 D
2026-03-19 Sale : show line 7 in the form 10b5-1 −1,461 $29.99 $43,815 40,702 D
Open-market sales · 14,311 sh · avg $31.92 · $456,835

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-19 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) −1,365 83,035 D
Loading xslF345X06/form4-03192026_100350.xml…